相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dysregulation of mitochondrial bioenergetics and quality control by HIV-1 Tat in cardiomyocytes
Farzaneh G. Tahrir et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Prevalence and predictors of long corrected QT interval in HIV-positive patients: a multicenter study
Sebastiano Gili et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2017)
HIV-1 Nef-induced cardiotoxicity through dysregulation of autophagy
Manish K. Gupta et al.
SCIENTIFIC REPORTS (2017)
Persistent Immune Activation and Carotid Atherosclerosis in HIV-Infected Ugandans Receiving Antiretroviral Therapy
Mark J. Siedner et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Patterns of Cardiovascular Mortality for HIV-Infected Adults in the United States: 1999 to 2013
Matthew J. Feinstein et al.
AMERICAN JOURNAL OF CARDIOLOGY (2016)
Enhanced autophagy in pulmonary endothelial cells on exposure to HIV-Tat and morphine: Role in HIV-related pulmonary arterial hypertension
Pranjali Dalvi et al.
AUTOPHAGY (2016)
HIV-Tat induces a decrease in IKr and IKs via reduction in phosphatidylinositol-(4,5)-bisphosphate availability
Zeineb Es-Salah-Lamoureux et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
Synergistic Enhancement of Antitumor Efficacy by PEGylated Multi-walled Carbon Nanotubes Modified with Cell-Penetrating Peptide TAT
Shanshan Hu et al.
NANOSCALE RESEARCH LETTERS (2016)
Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial
Erwann P. Loret et al.
RETROVIROLOGY (2016)
Synergistic Enhancement of Antitumor Efficacy by PEGylated Multi-walled Carbon Nanotubes Modified with Cell-Penetrating Peptide TAT
Shanshan Hu et al.
NANOSCALE RESEARCH LETTERS (2016)
Curcumin inhibits HIV-1 by promoting Tat protein degradation
Amjad Ali et al.
SCIENTIFIC REPORTS (2016)
Cardiac Dysfunction in HIV-1 Transgenic Mouse: Role of Stress and BAG3
Joseph Y. Cheung et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2015)
HIV-associated pulmonary arterial hypertension: from bedside to the future
Michele Correale et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2015)
HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial
Fabrizio Ensoli et al.
RETROVIROLOGY (2015)
Methamphetamine and HIV-Tat alter murine cardiac DNA methylation and gene expression
Christopher A. Koczor et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2015)
HIV related pulmonary arterial hypertension: epidemiology in Africa, physiopathology, and role of antiretroviral treatment
Jean Joel R. Bigna et al.
AIDS RESEARCH AND THERAPY (2015)
QTCinterval prolongation in HIV-negative versus HIV-positive subjects with or without antiretroviral drugs
Olarinde Jeffrey Ogunmola et al.
ANNALS OF AFRICAN MEDICINE (2015)
HIV-1-Tat excites cardiac parasympathetic neurons of nucleus ambiguus and triggers prolonged bradycardia in conscious rats
Eugen Brailoiu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2014)
Heart Failure in Patients With Human Immunodeficiency Virus Infection Epidemiology, Pathophysiology, Treatment, and Future Research
Joshua Remick et al.
CIRCULATION (2014)
HIV infection and cardiovascular disease
Lars G. Hemkens et al.
EUROPEAN HEART JOURNAL (2014)
Endothelial Dysfunction, Arterial Stiffening, and Intima-Media Thickening in Large Arteries from HIV-1 Transgenic Mice
Laura Hansen et al.
ANNALS OF BIOMEDICAL ENGINEERING (2013)
HIV Tat Induces Expression of ICAM-1 in HUVECs: Implications for miR-221/-222 in HIV-Associated Cardiomyopathy
Ming Duan et al.
PLOS ONE (2013)
The impact of HAART on cardiomyopathy among children and adolescents perinatally infected with HIV-1
Kunjal Patel et al.
AIDS (2012)
Enhanced Pulmonary Arteriopathy in Simian Immunodeficiency Virus-infected Macaques Exposed to Morphine
Leslie Spikes et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Analysis of the effects of HIV-1 Tat on the survival and differentiation of vessel wall-derived mesenchymal stem cells
Davide Gibellini et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals
Daniel A. Duprez et al.
PLOS ONE (2012)
HIV Tat protein inhibits hERG K+ channels: A potential mechanism of HIV infection induced LQTs
Yun-Long Bai et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Prevalence of Cardiac Diastolic Dysfunction in HIV-Infected Patients: Results of the HIV-HEART Study
Nico Reinsch et al.
HIV CLINICAL TRIALS (2010)
Impact of Viral Dose and Major Histocompatibility Complex Class IB Haplotype on Viral Outcome in Mauritian Cynomolgus Monkeys Vaccinated with Tat upon Challenge with Simian/Human Immunodeficiency Virus SHIV89.6P
Aurelio Cafaro et al.
JOURNAL OF VIROLOGY (2010)
Crystal structure of HIV-1 Tat complexed with human P-TEFb
Tahir H. Tahirov et al.
NATURE (2010)
Therapeutic Immunization with HIV-1 Tat Reduces Immune Activation and Loss of Regulatory T-Cells and Improves Immune Function in Subjects on HAART
Barbara Ensoli et al.
PLOS ONE (2010)
HIV type 1 infection, and not short-term HAART, induces endothelial dysfunction
Daniela Francisci et al.
AIDS (2009)
Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis
Priscilla Y. Hsue et al.
AIDS (2009)
Dilated Cardiomyopathy in Transgenic Mice Expressing HIV Tat
Qiujuan Fang et al.
CARDIOVASCULAR TOXICOLOGY (2009)
Incomplete Peripheral CD4+ Cell Count Restoration in HIV-Infected Patients Receiving Long-Term Antiretroviral Treatment
Colleen F. Kelley et al.
CLINICAL INFECTIOUS DISEASES (2009)
Prevalence and Risk Factors of Prolonged QTc Interval in HIV-Infected Patients: Results of the HIV-HEART Study
Nico Reinsch et al.
HIV CLINICAL TRIALS (2009)
The protective role of curcumin in cardiovascular diseases
Wanwarang Wongcharoen et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2009)
Transgenic and Infectious Animal Models of HIV-Associated Nephropathy
Paul Rosenstiel et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men
Robert C. Kaplan et al.
AIDS (2008)
Cardiac repolarization is prolonged in CD4C/HIV transgenic mice
Judith Brouillette et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
The role of immunity and inflammation in the progression of atherosclerosis in patients with HIV infection
Blai Coll et al.
STROKE (2007)
Prevalence of dilated cardiomyopathy in HIV-infected African patients not receiving HAART: A multicenter, observational, prospective, cohort study in Rwanda
Marc Twagirumukiza et al.
CURRENT HIV RESEARCH (2007)
Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection
PY Hsue et al.
CIRCULATION (2004)
Estrogen-mediated protection against HIV Tat protein-induced inflammatory pathways in human vascular endothelial cells
YW Lee et al.
CARDIOVASCULAR RESEARCH (2004)
Prevalence of liver tumours in HIV-1 tat-transgenic mice treated with urethane
G Altavilla et al.
EUROPEAN JOURNAL OF CANCER (2004)
HIV Tat protein causes endothelial dysfunction in porcine coronary arteries
R Paladugu et al.
JOURNAL OF VASCULAR SURGERY (2003)
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
A Mocroft et al.
LANCET (2003)
General cardiology - HIV and cardiovascular medicine
BD Prendergast
HEART (2003)
Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline
BO Kim et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Elevated levels of tumor necrosis factor alpha (TNF-α) in human immunodeficiency virus type 1-transgenic mice:: Prevention of death by antibody to TNF-α
SK De et al.
JOURNAL OF VIROLOGY (2002)
Targeted myocardial transgenic expression of HIV Tat causes cardiomyopathy and mitochondrial damage
SM Raidel et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)
Cardiac dysfunction occurs in the HIV-1 transgenic mouse treated with zidovudine
W Lewis et al.
LABORATORY INVESTIGATION (2000)
分享论文
